INmune Bio, Inc.
NASDAQ:INMB
7.82 (USD) • At close April 25, 2025
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Omzet
| 0.014 | 0.155 | 0.374 | 0.181 | 0.011 | 77.688 | 0 | 0 | 0 | 0 |
| Kosten van de omzet
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Brutowinst
| 0.014 | 0.155 | 0.374 | 0.181 | 0.011 | 77.688 | 0 | 0 | 0 | 0 |
| Brutowinstmarge
| 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 |
| Onderzoek- en ontwikkelingskosten
| 33.166 | 20.273 | 17.067 | 20.543 | 5.917 | 3.282 | 1.105 | 0.435 | 0.101 | 0 |
| Algemene en administratieve kosten
| 9.483 | 9.623 | 9.258 | 8.791 | 6.321 | 6.016 | 11.335 | 0.546 | 0.126 | 0.195 |
| Verkoop- en marketingkosten
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.147 |
| Verkoop-, algemene en administratieve kosten
| 9.483 | 9.623 | 9.258 | 8.791 | 6.321 | 6.016 | 11.335 | 0.546 | 0.126 | 0.049 |
| Overige kosten
| 0 | 0 | -1.348 | -1.187 | 0.129 | 0 | 0 | -0 | 0 | 0 |
| Bedrijfskosten
| 42.649 | 29.896 | 26.325 | 29.334 | 12.239 | 9.298 | 12.44 | 0.981 | 0.227 | 0.049 |
| Bedrijfsresultaat
| -42.635 | -29.741 | -25.951 | -29.153 | -12.228 | -7.756 | -12.44 | -0.981 | -0.227 | -0.049 |
| Bedrijfsresultaat ratio
| -3,045.357 | -191.877 | -69.388 | -161.066 | -1,120.161 | -0.1 | 0 | 0 | 0 | 0 |
| Totaal overige inkomsten en kosten netto
| 0.553 | -0.267 | -1.348 | -1.187 | 0.129 | 0.078 | 0 | 0.15 | -0.05 | 0 |
| Inkomen voor belasting
| -42.082 | -30.008 | -27.299 | -30.34 | -12.099 | -7.678 | -12.44 | -0.831 | -0.277 | -0.049 |
| Inkomen voor belasting ratio
| -3,005.857 | -193.6 | -72.992 | -167.624 | -1,108.388 | -0.099 | 0 | 0 | 0 | 0 |
| Belastingkosten
| 0 | 0 | 1.348 | -29.153 | -12.228 | 1.464 | -0.161 | -1.131 | -0.177 | 0 |
| Nettowinst
| -42.082 | -30.008 | -28.647 | -30.34 | -12.099 | -9.143 | -12.44 | -0.831 | -0.277 | -0.049 |
| Nettowinstmarge
| -3,005.857 | -193.6 | -76.596 | -167.624 | -1,108.388 | -0.118 | 0 | 0 | 0 | 0 |
| WPA (Winst Per Aandeel)
| -2.08 | -1.67 | -1.6 | -1.88 | -1.01 | -0.89 | -1.11 | -0.074 | -0.025 | -0.004 |
| Verwaterde WPA
| -2.08 | -1.67 | -1.6 | -1.88 | -1.01 | -0.89 | -1.11 | -0.074 | -0.025 | -0.004 |
| EBITDA
| -42.635 | -29.741 | 0 | 0 | 0 | 0 | 0 | 0.15 | -0.05 | 0.147 |
| EBITDA ratio
| -3,045.357 | -191.877 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |